Zevra Therapeutics, Inc. Common Stock (NASDAQ: ZVRA) last traded at $11.87, down 0.17% on the session. The quote above updates while this page is open; the figures below are drawn from Zevra Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Zevra Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker ZVRA. Its market capitalisation is $704.89 million.
Valuation measures for Zevra Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $704.89M |
|---|---|
| Enterprise value | $644.62M |
| P/E ratio | 12.63 |
| Price / sales | 5.18 |
| Price / book | 3.24 |
| Beta | 0.79 |
Trailing-twelve-month figures tagged in Zevra Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $136.07M |
|---|---|
| Net income (TTM) | $58.26M |
| EPS (TTM) | $0.940 |
| Operating margin | 60.54% |
| Return on equity | 26.77% |
| Cash | $145.32M |
Range and volume for ZVRA over the past 52 weeks.
| 52-week high | $15.04 |
|---|---|
| 52-week low | $7.16 |
| Volume | 685.0K |
| Average volume | 1.63M |
| Previous close | $11.89 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.